Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. [Crit Care. (2013), 17, (R117)], DOI: 10.1186/cc12789;Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Mehta, Sangeeta ^a   Granton, John ^b   Gordon, Anthony C ^c   Cook, D J ^p,s   Lapinsky, Stephen ^a   Newton, Gary ^a   Bandayrel, Kris ^a   Little, Anjuli ^a   Siau, Chuin ^e   Ayers, Dieter ^f   Singer, Joel ^f   Lee, Terry C K ^f   Walley, Keith R ^f,l   Storms, Michelle ^f   Cooper, D J ^g   Holmes, Cheryl L ^h   Hebert, Paul ⁱ   Presneill, J J ^s   Russell, James A ^f,l   Holmes, C ^s   Hebert, P C ^s   Storms, M M ^s   Mehta, S ^a,s   Jones, S ^s   Gasparini, A ^k   Dorscheid, D R ^l   Hameed, M ^l   Lazosky, L ^l   Helderweirt, S ^l   Foley, K ^l   Honeyman, C ^l   Terins, T ^l   Chittock, D ^m   Ronco, J ^m   Smith, L ^m   Logie, S ^m   Martinka, G ⁿ   Goulding, S ⁿ   Silverwood, S ⁿ   Leung, L ⁿ   Granton, J T ^o   Steinberg, M ^o   Matte, A ^o   McDonald, E ^p   Clarke, F ^o   Tkaczyk, A ^p   Zytaruk, N ^p   Stewart, T ^a   Suri, A ^a   Martinez Motta, C ^a   MacDonald, R ^a   Sivanantham, V ^a   Ward, M ^q   Santos, C Dos ^q   Friedrich, J ^q   Scales, D ^q   Smith, O ^q   DeCampos, I ^q   Richards, A ^q   Michalopoulos, H ^q   Bakshi, U ^q   Muscedere, J ^r   Diemer, C ^r   more..

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d MCMASTER UNIVERSITY   (Canada)

^e CHANGI GENERAL HOSPITAL   (Singapore)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j UNIVERSITY OF QUEENSLAND   (Australia)

^k CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^l ST PAUL S HOSPITAL   (Canada)

^m VANCOUVER GENERAL HOSPITAL   (Canada)

ⁿ Richmond General Hospital   (Canada)

^o TORONTO WESTERN HOSPITAL   (Canada)

^p ST JOSEPH S HOSPITAL   (Canada)

^q ST MICHAEL'S HOSPITAL   (Canada)

^r Hotel Dieu Grace Hospital Windsor   (Canada)

^s NONE

more..

Author keywords

electrocardiogram; myocardial ischemia; norepinephrine; Septic shock; troponin; vasopressin

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; NORADRENALIN; TROPONIN I; TROPONIN T; VASOPRESSIN; BIOLOGICAL MARKER; VASOPRESSIN DERIVATIVE;

ADULT; AGED; APACHE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECG ABNORMALITY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; BLOOD; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PROCEDURES; SHOCK, SEPTIC;

ADULT; AGED; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TROPONIN T; VASOPRESSINS;

EID: 84879073139     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-017-1680-7     Document Type: Erratum

References (33)

1. Lim W, Whitlock R, Khera V, Devereaux PJ, Tkaczyk A, Heels-Ansdell D, Jacka M, Cook D. Etiology of troponin elevation in critically ill patients. J Crit Care 2010, 25:322-328. 10.1016/j.jcrc.2009.07.002, 19781898.
2. Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med 2011, 183:847-855. 10.1164/rccm.201006-0972CI, 21097695.
3. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D. for the VASST Investigators A randomised controlled trial of low dose vasopressin versus norepinephrine infusion in patients who have septic shock. N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373, 18305265, for the VASST Investigators.
4. Ouattara A, Landi M, Le Manach Y, Lecomte P, Leguen M, Boccara G, Coriat P, Riou B. Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesiology 2005, 102:85-92. 10.1097/00000542-200501000-00016, 15618791.
5. Boyle WA 3, Segel LD. Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart. Circ Res 1990, 66:710-21. 10.1161/01.RES.66.3.710, 2306803.
6. Mehta S, Granton JT, Lapinsky S, Newton G, Bandayrel K, Little A, Siau C, Cook DJ, Ayers D, Singer J, Walley KR, Storms M, Cooper DJ, Holmes CL, Hebert P, Gordon AC, Presneill J, Russell JA. for the Vasopressin and Septic Shock Trial (VASST) Investigators Agreement in ECG interpretation in patients with septic shock. Crit Care Med 2011, 39:2080-2086. 10.1097/CCM.0b013e318222720e, 21849822, for the Vasopressin and Septic Shock Trial (VASST) Investigators.
7. Favory R, Neviere R. Bench-to-bedside review: significance and interpretation of elevated troponin in septic patients. Crit Care 2006, 10:224. 10.1186/cc4991, 1750983, 16895589.
8. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oeschslin E, Minder EI, Rickli H, Fehr T. Troponin as a risk factor in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003, 41:2004-2009. 10.1016/S0735-1097(03)00421-2, 12798573.
9. Lim W, Cook DJ, Griffith LE, Crowther MA, Devereaux PJ. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care 2006, 15:280-288.
10. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai H, Afessa B, Jaffe AS. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 2008, 36:759-765. 10.1097/CCM.0B013E318164E2E4, 18209672.
11. Lim W, Holinski P, Devereaux PJ, Tkaczyk A, McDonald E, Clarke F, Qushmaq I, Terrenato I, Schunemann H, Crowther M, Cook D. Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings. Crit Care 2008, 12:R36. Epub 2008 Mar 4, 10.1186/cc6815, 2447557, 18318915.
12. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, Crowther MA, Cook DJ. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med 2006, 166:2446-2454. 10.1001/archinte.166.22.2446, 17159009.
13. Reynolds T, Cecconi M, Collinson P, Rhodes A, Grounds RM, Hamilton MA. Raised serum cardiac troponin I concentrations predict hospital mortality in intensive care unit patients. Br J Anaesth 2012, 109:219-24. 10.1093/bja/aes141, 22617093.
14. Røsjø H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettilä V, Omland T. FINNSEPSIS Study Group Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011, 37:77-85. Epub 2010 Oct 12, 10.1007/s00134-010-2051-x, 3020309, 20938765, FINNSEPSIS Study Group.
15. Scott EC, Ho HC, Yu M, Chapital AD, Koss W, Takanish DM. Pre-existing cardiac disease, troponin elevation and mortality in patients with severe sepsis and septic shock. Anaesth Intensive Care 2008, 36:51-59.
16. Brivet FG, Jacobs FM, Colin P, Prat D, Grigoriu B. Cardiac troponin level is not an independent predictor of mortality in septic patients requiring intensive care unit admission [letter]. Critical Care 2006, 10:404. doi:10.1186/cc3990, 10.1186/cc3990, 1550832, 16469132.
17. Kalla C, Raveh D, Algur N, Rudensky B, Yinnon AM, Balkin J. Incidence and significance of a positive troponin test in bacteremic patients without acute coronary syndrome. Am J Med 2008, 121:909-915. 10.1016/j.amjmed.2008.05.037, 18823863.
18. Oliveira NS, Silva VR, Castelo JS, Elias-Neto J, Pereira FEL, Carvalho WB. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock. Pediatr Crit Care Med 2008, 9:414-417. 10.1097/PCC.0b013e31817e2b33, 18843251.
19. Choon-ngarm T, Partpisanu P. Serum cardiac troponin-T as a prognostic marker in septic shock. J Med Assoc Thai 2008, 91:1818-1821.
20. Spies C, Haude V, Fitzner R, Schroder K, Overbeck M, Runkel N, Schaffartzik W. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113:1055-1063. 10.1378/chest.113.4.1055, 9554647.
21. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, Gandini C. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med 2000, 26:31-37. 10.1007/s001340050008, 10663277.
22. John J, Woodward DB, Wang Y, Yan SB, Fisher D, Kinasewitz GT, Heiselman D. Troponin-I as a prognosticator of mortality in severe sepsis patients. J Crit Care 2010, 25:270-275. 10.1016/j.jcrc.2009.12.001, 20149590.
23. Landesberg F, Vesselov Y, Einav S, Goodman S, Sprung CL, Weissman C. Myocardial ischemia, cardiac troponin, and long-term survival of high-risk critically ill intensive care unit patients. Crit Care Med 2005, 33:1281-1287. 10.1097/01.CCM.0000166607.22550.87, 15942345.
24. Kress JP, Vinayak AG, Levitt J, Schweickert WD, Gehlbach BK, Zimmerman F, Pohlman AS, Hall JB. Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease. Crit Care Med 2007, 35:365-371. 10.1097/01.CCM.0000254334.46406.B3, 17205005.
25. Frazier SK, Brom H, Widener J, Pender L, Stone KS, Moser DK. Prevalence of myocardial ischemia during mechanical ventilation and weaning and its effects on weaning success. Heart Lung 2006, 35:363-373. 10.1016/j.hrtlng.2005.12.006, 17137937.
26. Luckner G, Dunser MW, Jochberger S, Mayr VD, Wenzel V, Ulmer H, Schmid S, Knotzer H, Pajk W, Hasibeder W, Mayr AJ, Friesenecker B. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005, 33:2659-2666. 10.1097/01.CCM.0000186749.34028.40, 16276194.
27. Luckner G, Mayr VD, Jochberger S, Wenzel V, Ulmer H, Hasibeder WR, Dünser MW. Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Crit Care Med 2007, 35:2280-2285. 10.1097/01.CCM.0000281853.50661.23, 17944015.
28. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001, 27:1416-1421. 10.1007/s001340101014, 11511958.
29. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96:576-582. 10.1097/00000542-200203000-00011, 11873030.
30. Okamura T, Ayajiki K, Fujioka H, Toda N. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens 1999, 17:673-678. 10.1097/00004872-199917050-00011, 10403611.
31. Nazari A, Sadr SS, Faghihi M, Imani A, Moghimian M. The cardioprotective effect of different doses of vasopressin (AVP) against ischemia-reperfusion injuries in the anesthetized rat heart. Peptides 2011, 32:2459-2466. Epub 2011 Nov 3, 10.1016/j.peptides.2011.10.023, 22079221.
32. Dünser MW, Mayr AJ, Stallinger A, Ulmer H, Ritsch N, Knotzer H, Pajk W, Mutz NJ, Hasibeder WR. Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 2002, 28:746-751. Epub 2002 Apr 30, 10.1007/s00134-002-1265-y, 12107681.
33. Gordon AC, Wang N, Walley KR, Ashby B, Russell JA. The cardiopulmonary effects of vasopressin compared to norepinephrine in septic shock. Chest 2012, 142:593-605. 10.1378/chest.11-2604, 22518026.